BC-05, an orally active inhibitor targeting CD13 and the proteasome, displays potent inhibition with IC50 values of 0.13 µM against human CD13 and 1.39 µM for the 20S proteasome. It is utilized in the research of multiple myeloma [1].
Molecular Weight:
464.27
CAS Number:
[2260717-73-3]
Formula:
C21H29BN2O9
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
